Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04017130 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) |
| First Submitted : | July 10, 2019 |
| First Submitted that Met QC Criteria : | July 10, 2019 |
| First Posted : | July 12, 2019 |
| Last Update Submitted that Met QC Criteria : | October 2, 2020 |
| Last Update Posted : | October 6, 2020 |